A research study is currently enrolling paroxysmal afib patients (those with afib that comes and goes) to evaluate the effectiveness of an experimental drug. The study, being conducted in the US and Canada, will determine how well the study medication reduces the amount of time your heart is in afib. Learn more and see if …
Read More
While attending several recent medical conferences, we learned about some interesting procedure clinical trials that may be of interest to the afib patient community. To learn more, check out the following studies: The nContact CONVERGE Trial Will Study the Convergent Procedure for Treatment of Persistent Atrial Fibrillation The reMARQable Trial Will Study the nMARQ Multielectrode …
Read More
Up to 30% of patients could have very late recurrence of atrial fibrillation after catheter ablation, according to research highlighted at the recent Boston AF Symposium. Very late recurrence, which is when atrial fibrillation resumes more than one year after ablation, may be the result of age, gender, type of afib, and existence of other …
Read More
At Heart Rhythm 2010, there was an update on the results of the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial that involved patients who received cryoablation using the Arctic Front® Cardiac CryoAblation Catheter System. At twelve months following these procedures, these younger, highly-symptomatic patients had better quality of life and dramatically decreased …
Read More
New research from Dr. Andrea Natale and colleagues on gender disparities in atrial fibrillation points out that women with afib are less likely to have catheter ablation treatment than men. When they do have atrial fibrillation catheter ablations, they tend to be older and sicker, meaning that they are more likely to have persistent or …
Read More
Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong. Learn more: Medtronic Clinical Trial …
Read More